 Home > Biochemistry News > Biotechnology News > Encapsulating innovative therapies such as trispecific cytokine inhibitors and cutting-edge immune-inflammatory diseases

Encapsulating innovative therapies such as trispecific cytokine inhibitors and cutting-edge immune-inflammatory diseases

 Last Update: 2022-05-01
 Source: Internet
 Author: User

Tags

omeprazole gluten free

sma drug

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On February 16, 2022, Equillium announced the acquisition of Bioniz Therapeutics

Through this acquisition, Equillium's immunology R&D pipeline and technology platform include:

BNZ-1: A potential "first-in-class" trispecific inhibitor that inhibits the inflammatory cytokines interleukin (IL)-2, IL-9 and IL-15 associated with various diseases

BNZ-2: a potential "first-in-class" selective inhibitor of IL-15 and IL-21

Discovery Platform: Bioniz's flexible, structure-based technology platform combined with deep insights into cytokine pathways and computational modeling creates discovery capabilities that result in highly differentiated immunology products

▲Bioniz product pipeline (picture source: Bioniz official website)

References:

[1] Equillium Acquires Bioniz Therapeutics Significantly Expanding Pipeline of Novel Immunomodulatory Drug Candidates.

(Original abridged)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

announcements today(81)

80 20 company(94)

united states logo(227)

single use technology(195)

healthy food name(42)

ups united states(221)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.